具有边缘型碳青霉烯类耐药的肺炎克雷伯菌分离株的耐药机制对碳青霉烯类药物接种物效应的影响。
Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.
机构信息
National Center for Infection Control, Ministry of Health, Tel Aviv, Israel; Section of Epidemiology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
National Center for Infection Control, Ministry of Health, Tel Aviv, Israel; Section of Epidemiology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
出版信息
Antimicrob Agents Chemother. 2015 Aug;59(8):5014-7. doi: 10.1128/AAC.00533-15. Epub 2015 May 18.
Abstract
We aimed to examine the effects of resistance mechanisms on several resistance phenotypes among carbapenem-resistant Klebsiella pneumoniae isolates with borderline carbapenem MICs. We compared carbapenemase-negative K. pneumoniae with carbapenemase-producing K. pneumoniae (CPKP) isolates with similar MICs. CPKP isolates exhibited a marked inoculum effect and were more resistant to the bactericidal effect of meropenem. This suggests that MIC measurements alone may not be sufficient in predicting the therapeutic efficacy of carbapenems against CPKP.
摘要
我们旨在研究耐药机制对几种碳青霉烯类药物中介耐碳青霉烯类肺炎克雷伯菌分离株耐药表型的影响。我们比较了碳青霉烯酶阴性肺炎克雷伯菌和碳青霉烯酶产生肺炎克雷伯菌（CPKP）分离株，它们的 MIC 相似。CPKP 分离株表现出明显的接种体效应，对美罗培南的杀菌作用更具耐药性。这表明，单独的 MIC 测量可能不足以预测碳青霉烯类药物对 CPKP 的治疗效果。
相似文献
1
Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.
Antimicrob Agents Chemother. 2015 Aug;59(8):5014-7. doi: 10.1128/AAC.00533-15. Epub 2015 May 18.
2
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
Clin Microbiol Infect. 2011 Aug;17(8):1135-41. doi: 10.1111/j.1469-0691.2011.03553.x. Epub 2011 Jun 2.
3
Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
Diagn Microbiol Infect Dis. 2013 Aug;76(4):486-90. doi: 10.1016/j.diagmicrobio.2013.04.006. Epub 2013 May 18.
4
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
Clin Microbiol Infect. 2012 Jan;18(1):61-6. doi: 10.1111/j.1469-0691.2011.03482.x. Epub 2011 Jul 1.
5
Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01923-18. Print 2019 Jan.
6
Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
Int J Antimicrob Agents. 2020 Apr;55(4):105930. doi: 10.1016/j.ijantimicag.2020.105930. Epub 2020 Mar 1.
7
Identification of Carbapenem-Resistant Klebsiella pneumoniae with Emphasis on New Delhi Metallo-Beta-Lactamase-1 (bla) in Bandar Abbas, South of Iran.
Microb Drug Resist. 2018 May;24(4):447-454. doi: 10.1089/mdr.2017.0058. Epub 2017 Oct 3.
8
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Infect Control Hosp Epidemiol. 2010 Dec;31(12):1250-6. doi: 10.1086/657135. Epub 2010 Oct 25.
9
Sequence Type 273 Carbapenem-Resistant Klebsiella pneumoniae Carrying and .
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00160-18. Print 2018 Jun.
10
Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen.
Int J Infect Dis. 2015 Apr;33:132-4. doi: 10.1016/j.ijid.2015.01.011. Epub 2015 Jan 15.
引用本文的文献
1
Whole-Genome Analysis of Multidrug-Resistant Klebsiella pneumoniae Kp04 Reveals Distinctive Antimicrobial and Arsenic-Resistance Genomic Features: A Case Study from Bangladesh.
Curr Microbiol. 2024 Nov 29;82(1):22. doi: 10.1007/s00284-024-03996-z.
2
Evaluation of the synergistic potential and mechanisms of action for designed cationic antimicrobial peptides.
Heliyon. 2024 Mar 13;10(6):e27852. doi: 10.1016/j.heliyon.2024.e27852. eCollection 2024 Mar 30.
3
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and .
Antibiotics (Basel). 2024 Mar 21;13(3):285. doi: 10.3390/antibiotics13030285.
4
Inoculum effect of CTX-M-15, OXA-48, and KPC-2 producing Klebsiella pneumoniae on meropenem and ceftazidime-avibactam efficacy.
Eur J Clin Microbiol Infect Dis. 2024 Jan 13. doi: 10.1007/s10096-024-04749-3.
5
The carbapenem inoculum effect provides insight into the molecular mechanisms underlying carbapenem resistance in .
bioRxiv. 2023 Oct 4:2023.05.23.541813. doi: 10.1101/2023.05.23.541813.
6
Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing .
Antibiotics (Basel). 2023 May 8;12(5):872. doi: 10.3390/antibiotics12050872.
7
Activities and Inoculum Effects of Cefiderocol and Aztreonam-Avibactam against Metallo-β-Lactamase-Producing .
Microbiol Spectr. 2023 Jun 15;11(3):e0056923. doi: 10.1128/spectrum.00569-23. Epub 2023 May 8.
8
Treatment of Severe Infections Due to Metallo-Betalactamases in Critically Ill Patients.
Antibiotics (Basel). 2022 Jan 24;11(2):144. doi: 10.3390/antibiotics11020144.
9
A New Pharmacokinetic-Pharmacodynamic Model To Characterize the Inoculum Effect of Acinetobacter baumannii on Polymyxin B .
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0178921. doi: 10.1128/AAC.01789-21. Epub 2021 Nov 15.
10
Comparison of ertapenem non-susceptibility with 2-mercaptopropionic acid phenotypic tests in predicting NDM-1 and IMP-1 production in clinical isolates of Escherichia coli.
Caspian J Intern Med. 2020 Fall;11(4):426-431. doi: 10.22088/cjim.11.4.426.
本文引用的文献
1
Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13.
J Antimicrob Chemother. 2015 Jan;70(1):89-92. doi: 10.1093/jac/dku333. Epub 2014 Sep 8.
2
Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone.
Diagn Microbiol Infect Dis. 2014 Jan;78(1):12-5. doi: 10.1016/j.diagmicrobio.2013.10.003. Epub 2013 Oct 14.
3
Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
Antimicrob Agents Chemother. 2013 Nov;57(11):5258-65. doi: 10.1128/AAC.01069-13. Epub 2013 Aug 12.
4
Epidemiological and microbiological characteristics of an outbreak caused by OXA-48-producing Enterobacteriaceae in a neonatal intensive care unit in Jerusalem, Israel.
J Clin Microbiol. 2013 Sep;51(9):2926-30. doi: 10.1128/JCM.01049-13. Epub 2013 Jun 26.
5
Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test.
Antimicrob Agents Chemother. 2012 Dec;56(12):6437-40. doi: 10.1128/AAC.01395-12. Epub 2012 Oct 15.
6
Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.
Clin Microbiol Rev. 2012 Oct;25(4):682-707. doi: 10.1128/CMR.05035-11.
7
A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.
J Clin Microbiol. 2012 Oct;50(10):3180-5. doi: 10.1128/JCM.00987-12. Epub 2012 Jul 18.
8
Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile.
J Med Microbiol. 2012 Sep;61(Pt 9):1270-1279. doi: 10.1099/jmm.0.045799-0. Epub 2012 Jun 14.
9
Rapid detection of carbapenemase genes by multiplex real-time PCR.
J Antimicrob Chemother. 2012 Apr;67(4):906-9. doi: 10.1093/jac/dkr563. Epub 2012 Jan 9.
10
Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.
Antimicrob Agents Chemother. 2010 Oct;54(10):4201-7. doi: 10.1128/AAC.00008-10. Epub 2010 Jul 26.
Zotero 插件